Gustavo Godoy, MD
Orthopaedic Surgery · New Orleans, LANPI 1104185958
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $48,750 of the $75,835 with a category attached, or 64.3%. Globus Medical accounts for 87.0% of it on its own, with 39 other manufacturers making up the rest. Among orthopaedic surgery clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 331 payments — averaging $229.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$66K
- Avitus Orthopaedics, Inc.$4K
- Stryker$3K
- Zimmer Biomet$990
- Medacta USA, Inc.$255
- Johnson & Johnson$146
- plus $2K from 34 others
What the payments were for
- Consulting fees$48,75064%
- Speaking & faculty fees$13,63218%
- Travel & lodging$6,8309%
- Food & beverage$6,6239%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 140 | $65,961 |
| Avitus Orthopaedics, Inc. | 1 | $3,600 |
| Stryker | 97 | $3,236 |
| Zimmer Biomet | 5 | $990 |
| Medacta USA, Inc. | 7 | $255 |
| Johnson & Johnson(2 entities) | 5 | $146 |
| Convatec Inc. | 4 | $131 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $124 |
| Organogenesis Inc. | 3 | $114 |
| Amgen(2 entities) | 6 | $107 |
| Collegium Pharmaceutical, Inc. | 7 | $106 |
| Pacira Therapeutics, Inc. | 6 | $104 |
| Biocomposites Inc | 2 | $91 |
| Fidia Pharma USA Inc. | 5 | $90 |
| Davol Inc. | 2 | $83 |
| Gilead | 2 | $67 |
| Sanara Medtech Inc. | 1 | $59 |
| Vericel Corporation | 3 | $54 |
| Sentynl Therapeutics, Inc. | 3 | $37 |
| ERMI LLC | 2 | $37 |
| Pacira Pharmaceuticals Incorporated | 2 | $36 |
| Bone Support Inc. | 1 | $36 |
| Acera Surgical, Inc. | 1 | $34 |
| Medtronic | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Bioventus LLC | 2 | $26 |
| Anika Therapeutics, Inc. | 1 | $25 |
| Valinor Pharma, LLC | 1 | $23 |
| Smith+Nephew | 1 | $22 |
| Heron Therapeutics, Inc. | 1 | $22 |
| Averitas Pharma Inc. | 1 | $21 |
| Nalu Medical, Inc. | 1 | $21 |
| Assertio Therapeutics, Inc. | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $18 |
| AbbVie | 1 | $16 |
| Esaote North America, Inc. | 1 | $15 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| KCI USA, Inc. | 1 | $14 |
| Boston Scientific | 1 | $13 |
| Heraeus Medical, LLC. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Onvoy$26,001
- ExcelsiusGPS Robotic Navigation System$13,025
- Legacy Stelkast Knee$7,734
- Globus Trauma$6,800
- MAKO$861
- ROSA$784
- PROVIDENT HIP SYSTEM$721
- Excelsius - GPS$379
- A/R Femoral Nail$149
- Flexus$144
- PROVIDENCE$130
- Knees Product Portfolio$109
- Actify$100
How this compares
$75,835 in reported general payments places this provider in the 90th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 185 | $2,146 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 126 | $1,270 |
| Cefadroxil | 70 | $595 |
| Celecoxib | 16 | $502 |
| Tramadol Hcl | 94 | $459 |
| Gabapentin | 39 | $386 |
| Cephalexin | 18 | $344 |
| Meloxicam | 121 | $225 |
| Tizanidine Hcl | 35 | $183 |
| Ondansetron Hcl | 14 | $151 |
| Ibuprofen | 17 | $121 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $69 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in New Orleans
- Robert ZuraNew Orleans$597K
- Fernando SanchezNew Orleans$484K
- Matthew CableNew Orleans$79K
- Cameron KingNew Orleans$74K
- Ramin SadeghpourNew Orleans$37K
- Robert HuangNew Orleans$28K
- Leland McCluskeyNew Orleans$24K
- Willard MooreNew Orleans$23K
- Jessica RiveraNew Orleans$20K
- Richard MeyerNew Orleans$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.